Trial Profile
A Study to Evaluate the Safety and Pharmacokinetics of DHP107 in Patients With Advanced Solid Tumors Refractory to All Standard Treatments
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Paclitaxel
- Indications Solid tumours
- Focus Adverse reactions; First in man; Pharmacokinetics
- 30 Dec 2015 New trial record